| Product Code: ETC12942884 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia mRNA Vaccines and Therapeutics Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Gambia mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.7 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.9 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Gambia mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government investments in healthcare infrastructure and vaccination programs. |
4.2.2 Growing awareness about the benefits of mRNA vaccines and therapeutics in The Gambia. |
4.2.3 Rise in research and development activities focusing on mRNA technology in the country. |
4.3 Market Restraints |
4.3.1 Limited access to advanced healthcare facilities and technology in certain regions of The Gambia. |
4.3.2 High cost associated with mRNA vaccines and therapeutics may hinder widespread adoption in the market. |
5 Gambia mRNA Vaccines and Therapeutics Market Trends |
6 Gambia mRNA Vaccines and Therapeutics Market, By Types |
6.1 Gambia mRNA Vaccines and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031F |
6.1.4 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Influenza Vaccine, 2021 - 2031F |
6.1.5 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Rabies Vaccine, 2021 - 2031F |
6.1.6 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Zika Virus Vaccine, 2021 - 2031F |
6.1.7 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By CMV Vaccine, 2021 - 2031F |
6.2 Gambia mRNA Vaccines and Therapeutics Market, By Therapeutic Type |
6.2.1 Overview and Analysis |
6.2.2 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.3 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031F |
6.2.4 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.2.5 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031F |
6.2.6 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By mRNA-Based Drug Delivery, 2021 - 2031F |
6.3 Gambia mRNA Vaccines and Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.5 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3.6 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.4 Gambia mRNA Vaccines and Therapeutics Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intramuscular Injection, 2021 - 2031F |
6.4.3 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Subcutaneous Injection, 2021 - 2031F |
6.4.4 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intradermal Injection, 2021 - 2031F |
6.4.5 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intravenous Infusion, 2021 - 2031F |
6.4.6 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oral Delivery, 2021 - 2031F |
6.5 Gambia mRNA Vaccines and Therapeutics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.4 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.5.6 Gambia mRNA Vaccines and Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 Gambia mRNA Vaccines and Therapeutics Market Import-Export Trade Statistics |
7.1 Gambia mRNA Vaccines and Therapeutics Market Export to Major Countries |
7.2 Gambia mRNA Vaccines and Therapeutics Market Imports from Major Countries |
8 Gambia mRNA Vaccines and Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials or research studies utilizing mRNA technology in The Gambia. |
8.2 Percentage increase in healthcare expenditure allocated to mRNA vaccines and therapeutics. |
8.3 Number of partnerships or collaborations between local and international pharmaceutical companies for mRNA products in The Gambia. |
9 Gambia mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
9.1 Gambia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Gambia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
9.3 Gambia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Gambia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.5 Gambia mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Gambia mRNA Vaccines and Therapeutics Market - Competitive Landscape |
10.1 Gambia mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Gambia mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here